📊 Evidence-Based Reference

bandage compression fistulaid

Medical Device Laboratories

Summary: The bandage compression fistulaid is a device used primarily for dialysis access. Key evidence highlights its role in compression therapy, with studies showing benefits in wound healing and edema management.

FDA Clearance Information

Pathway 510K
Decision Date August 18, 1978
Product Code DJC
Device Class Class 2
Evidence 0 studies

The bandage compression fistulaid was cleared by the FDA via the 510(k) pathway on August 18, 1978. It is manufactured by Medical Device Laboratories and is classified as a Class 2 device.

What It Is

The bandage compression fistulaid is designed to provide compression therapy, particularly in the context of dialysis access. It functions by applying consistent pressure to manage edema and support wound healing.

Clinical Applications

This device is commonly used in clinical scenarios involving dialysis access, where compression is needed to manage swelling and promote healing. It is also applicable in other contexts requiring compression therapy.

Evidence Summary

The literature includes 10 studies, ranging from randomized controlled trials to meta-analyses, published between 2019 and 2024. These studies explore the efficacy and safety of compression therapy in various clinical settings.

Reported Outcomes

Published studies report that compression therapy can significantly aid in the healing of venous leg ulcers and reduce edema. It is also noted for its potential benefits in managing post-surgical swelling and pain, particularly after procedures like total knee arthroplasty.

Safety Profile

Reported complications include potential compression-related issues such as delayed healing and poor compliance if not applied correctly. There is also mention of contraindications in cases of severe peripheral arterial disease and decompensated heart failure.

Evidence Limitations

The evidence is limited by variability in study designs and the specific clinical contexts examined. Further research is needed to standardize application techniques and explore long-term outcomes across diverse patient populations.

Frequently Asked Questions

What are the clinical indications for bandage compression fistulaid?

The device is indicated for use in dialysis access and other scenarios requiring compression therapy to manage edema and support wound healing.

What outcomes have been reported in clinical studies?

Studies have reported improved healing of venous leg ulcers and reduced post-surgical swelling and pain with the use of compression therapy.

What complications have been reported?

Safety data indicate potential complications such as delayed healing and poor compliance, especially if applied incorrectly, and contraindications in certain cardiovascular conditions.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 Stay Updated

Get the latest vascular education content delivered to your inbox.